Biofrontera (BFRI) Capital Expenditures Growth (3y) (2024 - 2025)

Biofrontera (BFRI) Capital Expenditures Growth (3y) (2024 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 6.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 232.22%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 34.64%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 147.53%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 28.56%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -15.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 89.86%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -61.38%
10 Biofrontera 8.65 Mn 2.24 Mn 14.09 Mn -44.22%

Historic Data

Download Data
DateValue
Dec 31, 2025 -44.22%
Sep 30, 2025 -44.22%
Jun 30, 2025 -68.17%
Mar 31, 2025 -15.66%
Dec 31, 2024 -86.09%